Background. Previous studies have demonstrated that elevated cholesterol results in increased white
Introduction
Leukocytes play important roles in immune regulation and tissue homeostasis 1 . Despite studies in animal models demonstrating a link between dyslipidaemia and increased leucocytosis, the impact of high plasma lipid levels on white blood cell counts in humans is poorly understood. With respect to animal models, Murphy, et al. 2 showed that accumulation of cholesterol in hematopoietic stem progenitor cells in apoE -/-mice increased responsiveness to IL-3 and granulocyte-macrophage colony-stimulating factor. This resulted in progenitor cell proliferation, leading to neutrophilia and monocytosis. Hypercholesterolaemia can also increase circulating levels of C-X-C motif ligand 1 (CXCL1), and increase expression of C-X-C chemokine receptor type 2 (CXCR2) in neutrophils, thereby inducing neutrophil release from bone marrow 3 .
A previous study of children with familial hypercholesterolaemia reported no relationship between cholesterol levels and neutrophil counts, but did identify a significant relationship between elevated HDL cholesterol levels and decreased monocyte numbers 4 . A recent study by Andersen et al. 5 using data from the United States National Health and Nutritional Examination Survey (NHANES)
found significant positive associations between triglyceride levels and lymphocyte, neutrophil, monocyte and basophil counts as well as sex-dependent inverse relationships between HDL cholesterol levels and leukocyte counts. Increased triglyceride (as remnant lipoproteins) has also been associated with increased total white blood cell, monocyte, lymphocyte and neutrophil counts 6 , and increased LDL cholesterol levels are associated with increased lymphocyte number 7, 8 . A modest positive association between non-HDL cholesterol levels and platelet counts has also been reported 9 .
It may also be important to consider the impact of dyslipidaemia on cellular function beyond simply influencing cell number. Changes in cholesterol homeostasis have been associated with alterations in monocyte subsets in humans 10 , and increased cellular cholesterol levels has been demonstrated to increase proliferation 11, 12 and inflammatory responses 13 in T lymphocytes.
As both increased lipids and the number of myeloid cells can have an impact on cardiovascular disease (CVD) risk, it is important to determine and understand the interactions between these factors.
We therefore investigated the relationship of different lipid measures with different types of white blood cell counts, and whether there were any sex or racial/ethnic differences in the relationship, using data from the Multi-Ethnic Study of Atherosclerosis (MESA) 14 .
Materials and Methods

Study participants
The Multi-Ethnic Study of Atherosclerosis (MESA) was designed to investigate the prevalence, risk factors and progression of subclinical cardiovascular disease (CVD) in a multi-ethnic cohort. Details of the study have been described previously 14 . Briefly, the study recruited 6814 men The participants underwent four follow up assessments (exams 2-5) over a period of 10 years.
Total white blood cell and subfraction counts were measured only at exam 5 (2010-2012) . Of the 6814 participants at baseline exam 1, 4716 participants attended exam 5, 2890 of whom had their white blood cell counts measured. After excluding 17 participants with missing data in one or more measures of plasma lipids (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides) at exam 5, a total of 2873 participants were included in the analysis.
Lipid and white blood cell measurements
Venous blood samples were collected in the morning after a 12-hour overnight fast by certified technicians using standardised venepuncture procedures. Total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides, as well as basophil, eosinophil, lymphocyte, monocyte, neutrophil and total white blood cell counts, were measured as described previously 15, 16 . Apolipoprotein E (APOE) genotype was estimated from single nucleotide polymorphisms rs429358 and rs7412 as described previously 17 . Serum glucose was measured by rate reflectance spectrophotometry using thin film adaptation of the glucose oxidase method. Diabetes was defined as fasting blood glucose ≥7.0 mmol/L (126 mg/dL) or use of hypoglycemic medication 18 . Serum creatinine was measured via rate reflectance spectrophotometry and calibrated to the standardised creatinine measurements obtained at the Cleveland Clinic Research Laboratory (Cleveland, OH). Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine using the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) Creatinine Equation 19 .
5. Details of the CVD and coronary revascularization event ascertainment has been described previously 20, 21 .
The height and weight of participants was measured to the nearest 0.1 cm and 0.5 kg, respectively, with participants wearing light clothing and no shoes. Body mass index (BMI) was calculated by dividing the height in metres squared by the weight in kilograms. Waist and hip circumference were measured in centimetres using a steel measuring tape. Resting blood pressure was measured in the right arm after 5 min in the seated position using an automated oscillometric method (Dinamap) and appropriate cuff size. Readings were taken three times, with the last two values averaged to obtain the blood pressure reading that was used for analysis. Hypertension was defined as blood pressure ≥140/90 mmHg or taking antihypertensive medication 22 . Inflammation and infectious-related conditions were defined as self-reported history of fever, cold/flu, urinary infection, seasonal allergy, bronchitis, sinus infection, pneumonia, tooth infection or impaired liver function over the past two weeks. Analysis of diagnostic residual plots suggested the normality of the model residuals was improved after ln-transformation of total white blood cell, monocyte, neutrophil and lymphocyte counts, but not for basophil and eosinophil counts. For these two blood cell types, ln-transformation was used in the main analysis to be consistent with other blood cell types and a previous MESA study 16 . Therefore, a sensitivity analysis was performed without ln-transformation for basophil and eosinophil counts. In another sensitivity analysis, the above analyses were repeated after further excluding 1158 participants taking lipid-lowering medication.
Statistical analysis
In a separate analysis, we assessed the non-linear relationship of lipid measures with different types of white blood cell counts using the STATA command "mvrs" which uses regression splines to model potentially nonlinear relationships. We allowed the relationship for the lipid exposure of interest to be nonlinear while assuming that the relationships of other confounding variables with different white blood cell counts were linear. In two situations where nonlinearity was present the approximate knot positions were used to fit linear regression analyses within strata defined by these thresholds.
Interactions with sex and race/ethnicity was estimated by including the interaction term in the regression model in the full sample after adjustment for the main effects of the covariates.
However, as the number of Chinese Americans was too small to make inferences about interaction, Chinese Americans were excluded from analysis of race/ethnicity interaction. Subgroup analysis was performed if there was a significant interaction. A two-tailed p<0.05 was considered to be statistically significant. Table 1 shows baseline characteristics of the 2873 participants. The cohort consisted of 42.8%
Results
Baseline Characteristics
non-Hispanic White Americans, 0.9% Chinese-Americans, 27.9% African-American and 28.3%
Hispanic-Americans. The mean age was 69.5 years and 52.9% were women. The mean total cholesterol, HDL cholesterol and LDL cholesterol levels were 180.8, 55.0 and 104.4 mg/dL respectively, whereas the median triglyceride levels were 93 mg/dL. The median total white blood cell counts levels were 5.8×10 3 /μL. As shown in Supplementary Table 1 , participants included in this analysis were younger, less likely to be Chinese Americans, and more likely to be non-Hispanic White or Hispanic Americans, compared to those participants not included in this study. Supplementary 
Association of total cholesterol levels with cell counts
In the fully adjusted model, a higher total cholesterol level was associated with a lower lntransformed total white blood cell count after adjusting for multiple testing correction (B=-0.028, p<0.001 with a 2.8% lower cell count per one SD increase in total cholesterol level (Supplementary Table 2 and Figure 1 ). When assessing different white blood cell types, a higher total cholesterol level was also significantly associated with lower ln-transformed monocyte count (B=-0.038, p=<0.001) and neutrophil count (B=-0.034, p=<0.001), with 3.7% and 3.4% lower cell count, respectively per one SD increase in total cholesterol level after multiple testing correction (Supplementary Table 2 and Figure 1 ). In the sensitivity analysis, whereby participants taking lipid-lowering medications were excluded, a higher total cholesterol level was also significantly associated with lower ln-transformed total white blood cell, monocyte and neutrophil counts (p=0.004, 0.006, and 0.009 respectively, Figure 2 ). In all the above analyses, no significant interaction with sex and race/ethnicity was observed.
In a separate analysis, we assessed the non-linear association of total cholesterol levels with total white blood cell and neutrophil counts. The regression spline analysis suggested that both the associations may be somewhat steeper at lower total cholesterol levels, and flatter at higher total cholesterol levels, with a threshold at approximately 155 and 204 mg/dL, respectively (Table 2) .
However, such non-linear associations were not found after excluding participants taking lipidlowering medications. No non-linear association was found for the different types of white blood cell counts.
In all above analyses, similar non-significant results after multiple testing correction were obtained when assessing basophil and eosinophil counts without ln-transformation (Supplementary
Figures 2 and 3).
Association of HDL cholesterol levels with cell counts
A higher HDL cholesterol level was significantly associated with a lower ln-transformed total white blood cell count in the full adjustment model (B=-0.016, p=0.018), with a 1.5% lower count per one SD increase in HDL cholesterol level after correcting for multiple comparisons (Supplementary Table 2 and Figure 1) . However, such association did not remain significant in the sensitivity analysis after excluding participants taking lipid-lowering medications ( Figure 2 ). When analysing different white blood cell types, no significant association was found after full adjustment and multiple testing correction (Supplementary Table 2 , and Figures 1 & 2) . In all the above analyses, no significant interaction with sex and race/ethnicity was found.
Similar non-significant results were obtained when assessing basophil and eosinophil counts without ln-transformation ( Supplementary Figures 2 and 3) . No non-linear association was found with total white blood cell counts and different types of white blood cell counts.
Association of LDL cholesterol levels with cell counts
A higher LDL cholesterol level was significantly associated with a lower ln-transformed total white blood cell count in the full adjustment model (B=-0.023, p<0.001), with a 2.3% lower cell count per one SD increase in LDL cholesterol level after multiple testing correction (Supplementary Table   2 and Figure 1 ). When assessing different white blood cell types, a higher LDL cholesterol level was also significantly associated with a lower ln-transformed monocyte count (B=-0.031, p<0.001) and neutrophil count (B=-0.028, p=0.002) with 3.0% and 2.7% lower cell counts, respectively per one SD increase in LDL cholesterol level in the full adjustment model after multiple testing correction. In a sensitivity analysis after excluding participants taking lipid-lowering drugs, a higher LDL cholesterol level was still significantly associated with a lower ln-transformed total white blood cell, monocyte and neutrophil counts (p=0.006, 0.007, and 0.013 respectively, Figure 2 ). In all the above analyses, no significant interaction with sex and race/ethnicity was found.
In a separate analysis, we assessed the non-linear association of LDL cholesterol levels with total white blood cell counts. The regression spline analysis suggested that the association may be somewhat steeper at lower LDL cholesterol levels, and flatter at higher LDL cholesterol levels, with a threshold at approximately 125 mg/dL (Table 2) . However, such non-linear association was not found after excluding participants taking lipid-lowering medications. No non-linear association was found for the different types of white blood cell counts.
In all above analyses, similar non-significant results were obtained after multiple testing correction when assessing basophil and eosinophil counts without ln-transformation. ( Supplementary   Figures 2 and 3) .
Association of triglyceride levels with cell counts
A higher ln-transformed triglyceride level was significantly associated with a higher lntransformed total white blood cell count in the full adjustment model after multiple testing correction (β=0.023, p<0.001) with a 2.3% higher cell count per one SD increase in ln-transformed triglyceride level (Supplementary Table 2 and Figure 1) . A significant interaction with race/ethnicity was found (p=0.005), but not with sex. The association was significant only in African Americans (p<0.001),
but not in non-Hispanic white Americans and Hispanic Americans (Supplementary Table 3 ). When assessing different types of white blood cell counts, a higher ln-transformed triglyceride level was associated with a higher ln-transformed lymphocyte count (B=0.044, p<0.001) in the full adjustment model after multiple testing correction (Supplementary Table 2 and Figure 1) , with a 4.5% higher lymphocyte count per one SD increase in ln-transformed triglyceride level. No significant interaction with sex and race/ethnicity was found. No significant association was found between triglyceride levels and other types of white blood cell counts after multiple testing correction.
In the sensitivity analysis after excluding participants taking lipid-lowering drugs, a higher lntransformed triglyceride level was still significantly associated with a higher ln-transformed total white blood cell count and a higher lymphocyte count after multiple testing correction (p=0.001 and <0.001 respectively, Figure 2 ). No significant interaction with sex or race/ethnicity was found.
In all above analyses, similar non-significant results were obtained when assessing basophil and eosinophil counts without ln-transformation ( Supplementary Figures 2 and 3) . No non-linear association was found with total white blood cell counts and different types of white blood cell counts.
Inflammation and infection related conditions as potential confounders
Since white blood cell counts can be elevated in inflammatory and infection related conditions, a sensitivity analysis was performed after excluding 1069 participants with these conditions. Similar to the main analysis, higher total and LDL cholesterol levels were associated with lower lntransformed total white blood cell, monocyte, and neutrophil counts, whereas higher triglyceride levels were associated with higher ln-transformed total white blood cell and lymphocyte counts (Supplementary Figure 4) . Interestingly, higher HDL cholesterol levels were found to be associated with a lower ln-transformed total white blood cell counts in this sensitivity analysis (p = 0.007, Supplementary Figure 4) , a relationship that was previously observed in the main cohort (Figure 1 ), but not in the sensitivity analysis after excluding participants taking lipid-lowering medication ( Figure 2 ). Similar non-significant results were obtained when assessing basophil and eosinophil counts without ln-transformation (Supplementary Figure 5) .
Discussion.
Using data from MESA, this study examined the relationships between various plasma lipids and a range of white blood cell counts in a multi-ethnic cohort. After adjusting for relevant co-variates, higher total cholesterol and LDL cholesterol levels were significantly associated with lower white blood cell, monocyte and neutrophil counts in all participants. Higher triglyceride levels were associated with higher total white blood cell and lymphocyte counts. Increased HDL cholesterol was associated with lower total white blood cell counts, but the association did not remain significant after excluding participants taking lipid-lowering medication. Despite these significant associations, the magnitudes of these associations were modest, with a one standard deviation change in lipid levels resulting in less than 5% change in corresponding white blood cell counts. The results of this study suggest that relationships between plasma lipid levels and white blood cell counts are not common amongst mice and humans.
Elevated cholesterol levels have been demonstrated to promote monocytosis in mice due to cholesterol accumulation and proliferation of hematopoietic stem progenitor cells (HSPCs) 2, 4, 23 .
Recently, van der Valk, et al. 24 reported that cholesterol accumulation can occur in human HSPCs and results in a myeloid differentiation bias in vitro. Whilst that study also reported increased glucose uptake in the bone marrow of subjects with familial hypercholesterolemia, suggesting increased bone marrow progenitor proliferation, monocyte, lymphocyte and neutrophil counts were not elevated in vivo. In light of the findings presented here, further investigation into the impact of cholesterol accumulation on the mechanisms underlying myeloid cell differentiation is needed.
Neutrophils play an important role in atherosclerosis. They accumulate preferentially in the shoulder regions of atherosclerotic plaques in mice, where there is also a high density of monocytes 3, 25, 26 . This is consistent with atherosclerotic lesion size in mice being positively correlated with neutrophil counts, suggesting a potential role of neutrophils in atherosclerotic lesion development 3 .
Indeed, several studies have shown that hypercholesterolaemia induces neutrophilia in mice 2, 27, 28 .
Similarly, a cross-sectional analysis by Huang, et al. 29 looking at the effect of hyperlipidaemia, smoking and BMI on peripheral differential leukocyte counts in humans also showed a positive correlation between LDL cholesterol and neutrophil counts. However, we found that elevated total cholesterol and LDL was associated with a significant, if modest, decrease in neutrophil counts.
Indeed, children with familial hypercholesterolaemia have normal neutrophil counts despite their high cholesterol levels 4 .
The effect of triglycerides on CVD risk is well established 30, 31 . Increased bone marrow glucose uptake, together with monocytosis and leukocytosis has been described in patients with familial dysbetalipoproteinaemia 6 , and increased triglyceride rich remnant cholesterol has been associated with increased total white blood cell, monocyte, neutrophil and lymphocyte counts in a large population 6 . Our analysis found an association of higher triglyceride levels with higher total white blood cell and lymphocyte counts similar to those previously described by Oda and colleagues 7, 8 , although the same relationship between LDL and lymphocyte number was not observed. Elevated circulating lymphocyte numbers may be due to increased lipid loaded, antigen presenting arterial wall macrophages 7 . However, as lymphocytes comprise a heterogenous group of cells, further studies are needed to identify which type of lymphocytes are affected by elevated triglyceride levels.
Our analysis found that monocyte counts were not associated with higher plasma triglyceride levels. Saja, et al. 32 demonstrated that in a murine model of hypertriglyceridaemia increased binding of Gr1 low monocytes to the endothelium and extravasation into the subendothelial space. This resulted in depletion of monocytes from the circulation and accumulation of macrophages in the heart, liver, and kidney. In this context, it may be important to determine the if there is any relationship between plasma lipid levels and monocyte flux in humans, as the number of monocytes in the blood represents only a snapshot of the balance between the emergence of cells from the bone marrow and migration of monocytes into peripheral tissues.
Inflammation and infection result in the elevation of different white blood cell counts, and may therefore have confounding effect on the relationship between lipids and white blood cell counts.
However, in the present analysis, excluding participants with inflammation and infection related diseases did not have any significant impact on the relationships observed between lipid levels and white blood cell counts. Future analyses could utilise datasets that include reliable direct measures of inflammation (such as CRP). This data was not available for a sufficient number of subjects in visit 5 of the MESA study but may be important in the context of HDL function that is known to be impaired under inflammatory conditions 33 , and persists for a significant period of time after the inflammatory event 34 .
Whilst the present study takes the advantage of a large well-characterised sample of with a multi-ethnic study design, there are some limitations. We were not able to definitively determine the familial hypercholesterolemia (FH) status of subjects included in our study. Future studies using larger populations with data on genetic mutations and/or relevant patient history may allow for more accurate status determination and assessment of the impact of FH on white blood cell counts. There was an under-representation of Chinese Americans in the present study, compared to the original parent cohort. Therefore, we could not assess ethnic differences for Chinese Americans. White blood cell profiles were only measured at exam 5 and not at baseline exam 1. As such, we could not assess the temporal relationship between changes in lipid measures and change in white blood cell counts.
The current analysis was not able to consider the potential confounding effect of medications that may affect white blood cell counts and inflammation status. As this was an observational study, further investigations are needed to determine the underlying mechanism of the associations and their clinical significance. Nevertheless, this is the largest study to date with multi-ethnic study design that has assessed the relationship between lipid measures and different white blood cell counts.
In conclusion, this study suggests modest associations between lipid levels and circulating indicate P values that did not remain significant after multiple testing correction. Data are expressed as mean ± SD, n (%), or median (interquartile range). MET, metabolic equivalent. Data are expressed as mean ± SD or n (%). Baseline characteristics were determined using a chisquare test for categorical variables, and an ANOVA test for continuous variables. Regression coefficient B (95% confidence interval) were expressed as ln-transformed cell counts (×10 3 /μL) per one SD unit increase in lipid levels.
Supplementary
Data on different white blood cell counts and triglycerides were ln-transformed in the analysis. 
